#AIEye
#Podcast 730: #Stocks discussed: (NasdaqGS: $AMZN) (NYSE: $ORCL) (NasdaqGS: $NVDA)
#artificialintelligence
AWS
Launching Infrastructure Region in Thailand, and Oracle and NVIDIA Announce
Multi-Year Partnership
Global
#AI in #ClinicalTrials Market to reach $4.8B by 2027
Vancouver, Kelowna, Delta, BC – October 18, 2022 – Investorideas.com,
a global investor news source covering Artificial Intelligence (AI) brings
you today’s edition of The
AI Eye-watching stock news, deal tracker and advancements in
artificial intelligence.
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2022/101822-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2022/artificial-intelligence/10181AMZN-ORCL-NVDA.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NasdaqGS:AMZN) (NYSE:ORCL) (NasdaqGS:NVDA)
Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced plans to launch an infrastructure
Region in Thailand. This AWS Asia Pacific (Bangkok) Region will “enable
developers, startups, and enterprises, as well as government, education, and
nonprofit organizations, to run their applications and serve end users from AWS
data centers located in Thailand.” Prasad Kalyanaraman, vice president of
Infrastructure Services at AWS, said:
“The
AWS Asia Pacific (Bangkok) Region will enable organizations to build with AWS technologies
like artificial intelligence and machine learning, data analytics, and Internet
of Things. With these new tools, AWS is empowering governments to better engage
with citizens, enterprises to innovate for their next phase of growth, and
entrepreneurs to build businesses and compete on a global scale."
Oracle Corporation (NYSE:ORCL) and NVIDIA Corporation (NasdaqGS:NVDA) have announced a multi-year partnership aimed at
helping customers solve business challenges with accelerated computing and AI,
by bringing the full NVIDIA accelerated computing stack to the Oracle Cloud
Infrastructure (OCI). Jensen Huang, CEO and founder, NVIDIA, said:
“Accelerated
computing and AI are key to tackling rising costs in every aspect of operating
businesses. Enterprises are increasingly turning to cloud-first AI strategies
that enable fast development and scalable deployment. Our partnership with
Oracle will put NVIDIA AI within easy reach for thousands of companies.”
Global
AI in Clinical Trials Market to reach $4.8B by 2027
A report published by Markets and Markets finds that the global AI
in Clinical Trials market is projected to grow from $1.5 billion USD in 2022 to
$4.8 billion by 2027, registering a compound annual growth rate (CAGR) of 25.6
percent in the forecast period. The following excerpt from the report’s
description outlines some factors influencing the market’s growth:
The
growing need to curb clinical trials costs and reduce time involved in the drug
development process, the rising adoption of cloud-based applications and
services, and the impending patent expiry of blockbuster drugs are some of the
key factors driving the growth of artificial intelligence in clinical trials
market.
However,
a shortage of AI workforce and ambiguous regulatory guidelines for medical
software and lack of data sets in this field are some of the factors expected
to restrain the growth of the AI in clinical trials market in the coming years.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit
here
About Investorideas.com -
Big Investing Ideas
We publish breaking stock
news, stock research, guest posts and create original top rated investing
podcasts, plus sector tag articles featuring up and coming companies and
industry leaders. Investor Idea’s
original branded content includes the Crypto
Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock
directories for AI and tech, biotech, cannabis, cleantech, crypto, defense,
gaming, health and wellness, mining, oil and gas, sports and water.
The
Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts
and most audio platforms available.
Visit the Podcast
page at Investorideas.com: https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must
adhere to regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact
Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment